UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Electrophysiological Indices of Automatic and Controlled Auditory Information Processing in First-Episode, Recent-Onset and Chronic Schizophrenia

Biological psychiatry (1969), 2006-04, Vol.59 (8), p.762-772

2006

Volltextzugriff (PDF)

Not Mismatch Negativity, but Modulation of Sensory N1 is Measured – Comment to Chen-Engerer et al

Neuroscience, 2023-02, Vol.512, p.133-134

Umbricht, Daniel

2023

Volltextzugriff (PDF)

Matrix metalloproteinase 9 levels and parvalbumin positive interneuron dysfunction

Neuropsychopharmacology (New York, N.Y.), 2022-01, Vol.47 (2), p.429-429

Umbricht, Daniel

2022

Volltextzugriff (PDF)

Cerebral blood flow predicts differential neurotransmitter activity

Scientific reports, 2018-03, Vol.8 (1), p.4074-11, Article 4074

2018

Volltextzugriff (PDF)

Glycine Transporter Type I (GlyT1) Inhibitor, Bitopertin: A Journey from Lab to Patient

Chimia, 2018-08, Vol.72 (7), p.477

2018

Volltextzugriff (PDF)

Translating glutamate: from pathophysiology to treatment

Science translational medicine, 2011-09, Vol.3 (102), p.102mr2

2011

Volltextzugriff (PDF)

Cognitive impairment in major depression and the mGlu2 receptor as a therapeutic target

Neuropharmacology, 2013-01, Vol.64, p.337-346

2013

Volltextzugriff (PDF)

Marked global reduction in mGluR5 receptor binding in smokers and ex-smokers determined by [¹¹C]ABP688 positron emission tomography

Proceedings of the National Academy of Sciences - PNAS, 2013-01, Vol.110 (2), p.737-742

2013

Volltextzugriff (PDF)

Placebo Response and Practice Effects in Schizophrenia Cognition Trials

JAMA psychiatry (Chicago, Ill.), 2017-08, Vol.74 (8), p.807

2017

Volltextzugriff (PDF)

Nailing the Right Dose! The Key for Developing Glycine Transporter Inhibitors for Schizophrenia

Biological psychiatry (1969), 2018-09, Vol.84 (6), p.394-395

Umbricht, Daniel

2018

Volltextzugriff (PDF)

Deep Learning-Based Human Activity Recognition for Continuous Activity and Gesture Monitoring for Schizophrenia Patients With Negative Symptoms

Frontiers in psychiatry, 2020-09, Vol.11, p.574375

2020

Volltextzugriff (PDF)

Social Anxiety in Children and Adolescents With Autism Spectrum Disorders Contribute to Impairments in Social Communication and Social Motivation

Frontiers in psychiatry, 2020-07, Vol.11, p.710-710

2020

Volltextzugriff (PDF)

How specific are deficits in mismatch negativity generation to schizophrenia?

Biological psychiatry (1969), 2003-06, Vol.53 (12), p.1120-1131

2003

Volltextzugriff (PDF)

Visual attention and inhibitory control in children, teenagers and adults with autism without intellectual disability: results of oculomotor tasks from a 2-year longitudinal follow-up study (InFoR)

Molecular autism, 2021-11, Vol.12 (1), p.71-71, Article 71

2021

Volltextzugriff (PDF)

Mismatch negativity predicts psychotic experiences induced by nmda receptor antagonist in healthy volunteers

Biological psychiatry (1969), 2002-03, Vol.51 (5), p.400-406

2002

Volltextzugriff (PDF)

Correction to: Visual attention and inhibitory control in children, teenagers and adults with autism without intellectual disability: results of oculomotor tasks from a 2-year longitudinal follow-up study (InFoR)

Molecular autism, 2022-01, Vol.13 (1), p.4-4, Article 4

2022

Volltextzugriff (PDF)

Optimizing Behavioral Paradigms to Facilitate Development of New Treatments for Anhedonia and Reward Processing Deficits in Schizophrenia and Major Depressive Disorder: Study Protocol

Frontiers in psychiatry, 2020-11, Vol.11, p.536112-536112

2020

Volltextzugriff (PDF)

Proof-of-Mechanism Study of the Phosphodiesterase 10 Inhibitor RG7203 in Patients With Schizophrenia and Negative Symptoms

Biological psychiatry global open science, 2021-06, Vol.1 (1), p.70-77

2021

Volltextzugriff (PDF)

Help-seeking pathways in early psychosis

Social Psychiatry and Psychiatric Epidemiology, 2006-12, Vol.41 (12), p.967-974

2006

Volltextzugriff (PDF)

Has an angel shown the way? Etiological and therapeutic implications of the PCP/NMDA model of schizophrenia

Schizophrenia bulletin, 2012-09, Vol.38 (5), p.958-966

2012

Volltextzugriff (PDF)

LETTER TO THE EDITOR REFERRING TO AISEN, P.S. AND R. RAMAN, FUTILITY ANALYSES IN ALZHEIMER’S DISEASE (AD) CLINICAL TRIALS: A RISKY BUSINESS. THE JOURNAL OF PREVENTION OF ALZHEIMER’S DISEASE, 2020

The Journal of Prevention of Alzheimer's Disease, 2020-08, p.1-2

Umbricht, D.

2020

Volltextzugriff (PDF)

Letter to the editor referring to P.S. Aisen and R. Raman, Futility Analyses in Alzheimer’s Disease (AD) Clinical Trials: A Risky Business. The Journal of Prevention of Alzheimer’s Disease, 2020

The journal of prevention of Alzheimer's disease, 2020, Vol.7 (4), p.299-300

Umbricht, Daniel

2020

Volltextzugriff (PDF)

Effects of clozapine on auditory event-related potentials in schizophrenia

Biological psychiatry (1969), 1998-10, Vol.44 (8), p.716-725

1998

Volltextzugriff (PDF)

General practitioners and schizophrenia: Results from a Swiss survey

British journal of psychiatry, 2005-09, Vol.187 (3), p.274-281

2005

Volltextzugriff (PDF)

A phase 2 clinical trial of a vasopressin V1a receptor antagonist shows improved adaptive behaviors in men with autism spectrum disorder

Science translational medicine, 2019-05, Vol.11 (491)

2019

Volltextzugriff (PDF)

1 – 25 von 101

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieSchizophrenia Research

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(93)
Mit Volltextzugriff
(81)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(68)
Life Sciences & Biomedicine
(65)
Humans
(56)
Psychiatry
(46)
Male
(36)
Adult
(31)
Schizophrenia
(31)
Female
(28)
Neurosciences
(25)
Neurosciences & Neurology
(24)
Biological And Medical Sciences
(22)
Medical Sciences
(21)
Psychology. Psychoanalysis. Psychiatry
(20)
Schizophrenia - Drug Therapy
(20)
Schizophrenic Psychology
(16)
Antipsychotic Agents - Therapeutic Use
(14)
Psychopathology. Psychiatry
(14)
Adult And Adolescent Clinical Studies
(13)
Psychology
(13)
Schizophrenia - Diagnosis
(13)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Electrophysiological Indices of Automatic and Controlled Auditory Information Processing in First-Episode, Recent-Onset and Chronic Schizophrenia

Not Mismatch Negativity, but Modulation of Sensory N1 is Measured – Comment to Chen-Engerer et al

Matrix metalloproteinase 9 levels and parvalbumin positive interneuron dysfunction

Cerebral blood flow predicts differential neurotransmitter activity

Glycine Transporter Type I (GlyT1) Inhibitor, Bitopertin: A Journey from Lab to Patient

Translating glutamate: from pathophysiology to treatment

Cognitive impairment in major depression and the mGlu2 receptor as a therapeutic target

Marked global reduction in mGluR5 receptor binding in smokers and ex-smokers determined by [¹¹C]ABP688 positron emission tomography

Placebo Response and Practice Effects in Schizophrenia Cognition Trials

Nailing the Right Dose! The Key for Developing Glycine Transporter Inhibitors for Schizophrenia

Deep Learning-Based Human Activity Recognition for Continuous Activity and Gesture Monitoring for Schizophrenia Patients With Negative Symptoms

Social Anxiety in Children and Adolescents With Autism Spectrum Disorders Contribute to Impairments in Social Communication and Social Motivation

How specific are deficits in mismatch negativity generation to schizophrenia?

Visual attention and inhibitory control in children, teenagers and adults with autism without intellectual disability: results of oculomotor tasks from a 2-year longitudinal follow-up study (InFoR)

Mismatch negativity predicts psychotic experiences induced by nmda receptor antagonist in healthy volunteers

Correction to: Visual attention and inhibitory control in children, teenagers and adults with autism without intellectual disability: results of oculomotor tasks from a 2-year longitudinal follow-up study (InFoR)

Optimizing Behavioral Paradigms to Facilitate Development of New Treatments for Anhedonia and Reward Processing Deficits in Schizophrenia and Major Depressive Disorder: Study Protocol

Proof-of-Mechanism Study of the Phosphodiesterase 10 Inhibitor RG7203 in Patients With Schizophrenia and Negative Symptoms

Help-seeking pathways in early psychosis

Has an angel shown the way? Etiological and therapeutic implications of the PCP/NMDA model of schizophrenia

LETTER TO THE EDITOR REFERRING TO AISEN, P.S. AND R. RAMAN, FUTILITY ANALYSES IN ALZHEIMER’S DISEASE (AD) CLINICAL TRIALS: A RISKY BUSINESS. THE JOURNAL OF PREVENTION OF ALZHEIMER’S DISEASE, 2020

Letter to the editor referring to P.S. Aisen and R. Raman, Futility Analyses in Alzheimer’s Disease (AD) Clinical Trials: A Risky Business. The Journal of Prevention of Alzheimer’s Disease, 2020

Effects of clozapine on auditory event-related potentials in schizophrenia

General practitioners and schizophrenia: Results from a Swiss survey

A phase 2 clinical trial of a vasopressin V1a receptor antagonist shows improved adaptive behaviors in men with autism spectrum disorder

Aktive Filter

Suchergebnisse filtern